Indivior Pharmaceuticals, Inc.
INDV
$36.76
-$1.07-2.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -12.75% | 137.21% | 138.89% | -61.70% | 123.81% |
| Total Depreciation and Amortization | -20.00% | 0.00% | 0.00% | 0.00% | -16.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 310.34% | -390.00% | -23.08% | 116.67% | -84.62% |
| Change in Net Operating Assets | 45.48% | -208.25% | -179.51% | 617.65% | 119.77% |
| Cash from Operations | 95.93% | -466.67% | -124.68% | 110.67% | 541.18% |
| Capital Expenditure | 16.67% | -20.00% | -17.65% | -240.00% | 68.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | 20.83% | -20.00% | -17.65% | -240.00% | -162.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6,560.00% | -25.00% | 0.00% | 0.00% | 98.32% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | -7,250.00% | -- | -- | 100.00% | 73.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | 100.00% | -- | -- |
| Cash from Financing | 240.00% | -66.67% | 40.00% | 70.59% | -142.50% |
| Foreign Exchange rate Adjustments | -- | 100.00% | -300.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -200.00% | -- | -- |
| Net Change in Cash | 92.00% | -284.62% | -147.10% | 160.38% | 65.63% |